JO2017B1 - تركيبة صيدلانية للاقامة المعدية - Google Patents
تركيبة صيدلانية للاقامة المعديةInfo
- Publication number
- JO2017B1 JO2017B1 JO19982017A JOP19982017A JO2017B1 JO 2017 B1 JO2017 B1 JO 2017B1 JO 19982017 A JO19982017 A JO 19982017A JO P19982017 A JOP19982017 A JO P19982017A JO 2017 B1 JO2017 B1 JO 2017B1
- Authority
- JO
- Jordan
- Prior art keywords
- gastric residence
- pharmaceutical
- composition
- carbon dioxide
- benzamide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
Abstract
تكوين صيدلي معدى، شريطة انه يشتمل على:- (1) مادة اساسية نشطة مكونة من بنزاميد او ملح ننزاميد (2) نظام مولد لثاني اكسيد الكربون (3) وسائل تسمح باحتفاظ جزئي بثاني اكسيد الكربون الناشئ عن نظام توليد ثاني اكسيد الكربون السابق .
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9704803A FR2762213B1 (fr) | 1997-04-18 | 1997-04-18 | Composition pharmaceutique a retention gastrique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JO2017B1 true JO2017B1 (ar) | 1999-05-15 |
Family
ID=9506077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JO19982017A JO2017B1 (ar) | 1997-04-18 | 1998-04-18 | تركيبة صيدلانية للاقامة المعدية |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0983065A1 (ar) |
| JP (1) | JP2001523241A (ar) |
| KR (1) | KR20010006353A (ar) |
| CN (1) | CN1252720A (ar) |
| AR (1) | AR015586A1 (ar) |
| AU (1) | AU737634B2 (ar) |
| CA (1) | CA2286081A1 (ar) |
| FR (1) | FR2762213B1 (ar) |
| HU (1) | HUP0002455A3 (ar) |
| IL (1) | IL131995A0 (ar) |
| JO (1) | JO2017B1 (ar) |
| MA (1) | MA26482A1 (ar) |
| NO (1) | NO995039L (ar) |
| NZ (1) | NZ500288A (ar) |
| PE (1) | PE68199A1 (ar) |
| PL (1) | PL336273A1 (ar) |
| TN (1) | TNSN98049A1 (ar) |
| WO (1) | WO1998047506A1 (ar) |
| ZA (1) | ZA983258B (ar) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6169094B1 (en) * | 1998-07-14 | 2001-01-02 | Sanofi-Synthelabo | Compositions of (S) (-)-amisulpride |
| FR2784583B1 (fr) * | 1998-10-16 | 2002-01-25 | Synthelabo | Composition pharmaceutique a residence gastrique et a liberation controlee |
| FR2790388B1 (fr) * | 1999-03-04 | 2001-04-13 | Synthelabo | Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption |
| EP1245227A1 (en) | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
| FR2949061B1 (fr) * | 2009-08-12 | 2013-04-19 | Debregeas Et Associes Pharma | Microgranules flottants |
| SI2719376T1 (sl) * | 2012-10-12 | 2015-06-30 | Omya International Ag | Gastrointestinalna zdravilna formulacija in razdeljevalni sistem in njen naäśin priprave z uporabo funkcionaliziranega kalcijevega karbonata |
| US10369134B2 (en) | 2017-12-05 | 2019-08-06 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| MX2020005517A (es) | 2017-12-05 | 2020-11-09 | Sunovion Pharmaceuticals Inc | Formas cristalinas y metodos de produccion de las mismas. |
| JP7044649B2 (ja) * | 2018-06-28 | 2022-03-30 | 株式会社ファンケル | 胃内浮遊錠剤 |
| WO2020247627A1 (en) | 2019-06-04 | 2020-12-10 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| WO2020247603A1 (en) * | 2019-06-04 | 2020-12-10 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| WO2023214018A1 (en) | 2022-05-06 | 2023-11-09 | Galenix Innovations | Gastro-retentive swellable sustained release composition |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2415099A1 (fr) * | 1978-01-20 | 1979-08-17 | Ile De France | Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes |
| FR2554718B1 (fr) * | 1983-11-14 | 1986-04-04 | Ethypharm Sa | Nouvelles formes galeniques du sulpiride utilisables par voie orale |
| FR2556964A1 (fr) * | 1983-12-23 | 1985-06-28 | Ile De France | Nouvelles formes galeniques du sulpiride utilisables par voie orale |
| JPS62178518A (ja) * | 1986-01-30 | 1987-08-05 | Toho Yakuhin Kogyo Kk | 新規持続性スルピリド錠剤 |
| JPH0776172B2 (ja) * | 1986-04-16 | 1995-08-16 | 藤沢薬品工業株式会社 | マトリツクス錠 |
| CA2039742A1 (en) * | 1990-04-23 | 1991-10-24 | Andrew B. Dennis | Tablet composition and method for problem pharmaceutical materials |
-
1997
- 1997-04-18 FR FR9704803A patent/FR2762213B1/fr not_active Expired - Fee Related
-
1998
- 1998-04-15 KR KR1019997009438A patent/KR20010006353A/ko not_active Withdrawn
- 1998-04-15 EP EP98920623A patent/EP0983065A1/fr not_active Ceased
- 1998-04-15 PL PL98336273A patent/PL336273A1/xx unknown
- 1998-04-15 WO PCT/FR1998/000755 patent/WO1998047506A1/fr not_active Ceased
- 1998-04-15 AU AU73416/98A patent/AU737634B2/en not_active Ceased
- 1998-04-15 CA CA002286081A patent/CA2286081A1/en not_active Abandoned
- 1998-04-15 CN CN98804269A patent/CN1252720A/zh active Pending
- 1998-04-15 NZ NZ500288A patent/NZ500288A/xx unknown
- 1998-04-15 IL IL13199598A patent/IL131995A0/xx unknown
- 1998-04-15 HU HU0002455A patent/HUP0002455A3/hu unknown
- 1998-04-15 JP JP54514398A patent/JP2001523241A/ja active Pending
- 1998-04-16 TN TNTNSN98049A patent/TNSN98049A1/fr unknown
- 1998-04-17 MA MA25037A patent/MA26482A1/fr unknown
- 1998-04-17 AR ARP980101773A patent/AR015586A1/es unknown
- 1998-04-17 ZA ZA983258A patent/ZA983258B/xx unknown
- 1998-04-17 PE PE1998000281A patent/PE68199A1/es not_active Application Discontinuation
- 1998-04-18 JO JO19982017A patent/JO2017B1/ar active
-
1999
- 1999-10-15 NO NO995039A patent/NO995039L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2762213A1 (fr) | 1998-10-23 |
| CN1252720A (zh) | 2000-05-10 |
| KR20010006353A (ko) | 2001-01-26 |
| TNSN98049A1 (fr) | 2005-03-15 |
| AU7341698A (en) | 1998-11-13 |
| HUP0002455A3 (en) | 2001-01-29 |
| PE68199A1 (es) | 1999-07-15 |
| AR015586A1 (es) | 2001-05-16 |
| NO995039L (no) | 1999-12-17 |
| CA2286081A1 (en) | 1998-10-29 |
| AU737634B2 (en) | 2001-08-23 |
| HUP0002455A2 (hu) | 2000-12-28 |
| NZ500288A (en) | 2001-03-30 |
| IL131995A0 (en) | 2001-03-19 |
| EP0983065A1 (fr) | 2000-03-08 |
| MA26482A1 (fr) | 2004-12-20 |
| JP2001523241A (ja) | 2001-11-20 |
| WO1998047506A1 (fr) | 1998-10-29 |
| PL336273A1 (en) | 2000-06-19 |
| FR2762213B1 (fr) | 1999-05-14 |
| NO995039D0 (no) | 1999-10-15 |
| ZA983258B (en) | 1998-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2282366B (en) | Device for delivering an audible message | |
| AP9801392A0 (en) | Concentrated antibody preparation. | |
| EP0662935A4 (en) | GAS GENERATOR. | |
| EP0646354A3 (en) | Autonomous surgical device, activated by a gas cartridge. | |
| ZA987126B (en) | Aryloxyarylsulfonylamino hydroxamic acid derivatives. | |
| EP0636617A3 (de) | Verfahren zur Herstellung von N-(2-Hydroxyethyl)-piperazin. | |
| BG102947A (en) | Ionic conjugates with delayed release | |
| GR3034289T3 (en) | Di- and trivalent small molecule selectin inhibitors | |
| EP0659769A3 (en) | Means to promote the proliferation of Bifidobacterium. | |
| JO2017B1 (ar) | تركيبة صيدلانية للاقامة المعدية | |
| BG103714A (en) | Pararacetamol-containing tablet | |
| EP0449787A3 (en) | Pharmaceutical, dietetic or veterinary compositions with eumetabolic activity | |
| BG103677A (en) | Solid mixtures based on sulphonylcarbamides and adjuvants | |
| MY128260A (en) | Cyclopentane-and-pentene-b-amino acids | |
| DK1044064T3 (da) | Overtrækningsindretning til granula til indtagelse ad oral vej | |
| TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
| NZ308516A (en) | Transdermal therapeutic system (tts) for administering testosterone | |
| EP0607897A3 (en) | Hydraulically-damped, active engine support. | |
| FR2704931B1 (fr) | Réservoir notamment bouteille de gaz. | |
| HUT41002A (en) | Process for preparing anticonvulsives | |
| ZA966885B (en) | Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors. | |
| EP0646505A3 (en) | Gas generator device. | |
| AU580890B2 (en) | P-acylaminobenzamides | |
| EP1018336A4 (en) | carcinostatic | |
| TW348157B (en) | Equipment and method to hold and to protect objects |